Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 202.50

-2.7%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: bob zagorin who wrote (31270)	2/25/2003 4:52:57 PM
From: Biomaven	Read Replies (1) of 32384

Can anyone reconcile the reduced sales they show for Targretin/Panretin gel in 2002 ($3.4m down from $6.6m) with the increased prescriptions they cite? Prescriptions for Targretin gel continued to show solid growth in 2002, increasing 24% compared to 2001. In the fourth quarter of 2002, Targretin gel prescriptions were up 22% compared to the prior year period. Underlying demand continued to accelerate in the second half of 2002 and hit record levels in the fourth quarter, which is increasingly reflected in wholesaler purchase patterns. Fourth quarter 2002 demand compared to earlier quarters is described in the following table: Versus 3Q Versus 2Q Versus 1Q 2002 2002 2002 ---------------------------------------------------------------------- ONTAK (unit shipments to end users) +12% +29% +27% Targretin capsules (prescriptions) +15% +14% +23% Targretin capsules (number of capsules) +10% +18% +27% Targretin gel (prescriptions) +12% +12% +27% Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next